Mizuho Securities USA LLC Grows Stock Holdings in Aimei Health Technology Co., Ltd (NASDAQ:AFJK)

Mizuho Securities USA LLC increased its stake in shares of Aimei Health Technology Co., Ltd (NASDAQ:AFJK) by 102.6% in the 4th quarter, Holdings Channel reports. The firm owned 897,220 shares of the company’s stock after buying an additional 454,442 shares during the period. Mizuho Securities USA LLC owned 0.10% of Aimei Health Technology worth $9,421,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently made changes to their positions in the stock. Wolverine Asset Management LLC grew its position in Aimei Health Technology by 21.3% during the fourth quarter. Wolverine Asset Management LLC now owns 654,039 shares of the company’s stock valued at $6,998,000 after buying an additional 115,000 shares during the period. Glazer Capital LLC grew its position in Aimei Health Technology by 3.4% during the third quarter. Glazer Capital LLC now owns 608,670 shares of the company’s stock valued at $6,379,000 after buying an additional 19,896 shares during the period. Rivernorth Capital Management LLC grew its position in Aimei Health Technology by 9.1% during the third quarter. Rivernorth Capital Management LLC now owns 172,789 shares of the company’s stock valued at $1,811,000 after buying an additional 14,391 shares during the period. Finally, Virtu Financial LLC bought a new stake in Aimei Health Technology during the third quarter valued at approximately $123,000. 45.58% of the stock is owned by hedge funds and other institutional investors.

Aimei Health Technology Stock Performance

Shares of NASDAQ AFJK opened at $11.01 on Friday. The firm has a 50 day moving average of $10.87 and a 200 day moving average of $10.67. Aimei Health Technology Co., Ltd has a 12-month low of $10.20 and a 12-month high of $11.01.

Aimei Health Technology Company Profile

Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors.